Argent Trust’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-1,224
Closed -$292K 205
2017
Q1
$292K Buy
1,224
+10
+0.8% +$2.33K 0.08% 175
2016
Q4
$255K Buy
1,214
+9
+0.7% +$1.86K 0.07% 182
2016
Q3
$277K Buy
1,205
+88
+8% +$21.5K 0.08% 173
2016
Q2
$258K Buy
+1,117
New +$258K 0.08% 177
2015
Q4
Sell
-845
Closed -$230K 205
2015
Q3
$230K Sell
845
-42
-5% -$12.9K 0.26% 90
2015
Q2
$269K Sell
887
-25
-3% -$7.46K 0.26% 86
2015
Q1
$271K Hold
912
0.27% 83
2014
Q4
$235K Buy
+912
New +$228K 0.21% 91

Other funds holding AGN

Argent Trust's AGN Position: Q2 2017 in Review

Argent Trust sold out of Allergan plc (AGN) in Q2 2017, closing a stake of 1,224 shares — an estimated $292K sold.

Argent Trust first reported a position in AGN in Q4 2014 and held it in 8 quarters. The position peaked at $292K in Q1 2017. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

  • Argent Trust reported no remaining Allergan plc position as of Q2 2017 after selling out during the quarter.
  • Argent Trust sold 1,224 Allergan plc shares in Q2 2017, an estimated $292K.
  • Argent Trust first reported a position in Allergan plc in Q4 2014 and held it in 8 quarters.
  • Argent Trust's Allergan plc position peaked at $292K in Q1 2017.
  • 1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Argent Trust's 13F filing for Q2 2017, filed 10 Aug 2017.